Suspension of trading
Sector Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 17/05/2024 BST
|
5-day change | 1st Jan Change | ||
| 15.13 USD | -0.13% |
|
-.--% | - |
| 20/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
| 20/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.13% | -.--% | -.--% | -.--% | -.--% | -.--% | +23.71% | +226.78% | -66.00% | 224M | |
| -0.56% | -8.30% | -6.50% | +8.02% | -0.52% | -5.88% | +10.58% | -30.66% | +193.15% | 46.38B | |
| -2.08% | -2.81% | -0.88% | +35.97% | +155.30% | +396.70% | +533.09% | +565.63% | - | 44.51B | |
| +0.12% | -2.48% | +7.79% | +38.15% | +14.15% | +35.68% | +20.50% | -1.52% | +233.85% | 42.3B | |
| -2.62% | -5.52% | -1.86% | +27.46% | +12.50% | -2.66% | +77.44% | +1.32% | +1,028.80% | 39.91B | |
| -1.26% | -2.95% | -9.28% | +6.35% | +4.88% | +12.00% | +40.55% | -18.25% | +136.05% | 32.79B | |
| +0.16% | -2.27% | +2.28% | +22.51% | - | - | - | - | - | 17.13B | |
| -0.54% | -1.66% | -1.27% | +24.93% | +3.83% | +20.09% | +115.10% | +201.86% | +1,873.47% | 16.36B | |
| -0.03% | -2.56% | +1.60% | +9.14% | +13.65% | +10.88% | +30.90% | -42.86% | +88.22% | 14.31B | |
| -1.92% | -6.43% | +2.06% | +43.80% | +36.86% | +73.47% | +36.68% | -38.37% | +246.62% | 13.29B | |
| +3.87% | +3.66% | +0.72% | +9.14% | -9.07% | -1.92% | -33.76% | -36.02% | +120.51% | 12.31B | |
| -4.14% | -5.17% | +12.85% | +20.32% | -0.52% | -27.49% | - | - | - | 11.06B | |
| -0.24% | -0.30% | -0.29% | +32.48% | +22.56% | +32.99% | +0.36% | -43.26% | +171.69% | 11.33B | |
| -0.34% | -1.19% | -8.24% | +87.16% | +46.15% | +30.70% | +53.66% | -51.30% | - | 10.49B | |
| -0.89% | +3.78% | -12.09% | +16.90% | -16.69% | +31.28% | +490.00% | +179.78% | +2,426.45% | 10.25B | |
| -1.95% | -5.30% | -6.15% | +35.25% | +14.87% | +745.79% | +1,523.84% | +11.85% | - | 9.64B | |
| +1.36% | -1.37% | +8.82% | +52.13% | +50.37% | +169.09% | +517.74% | +82.33% | - | 9.6B | |
| -4.99% | -10.66% | +39.25% | +177.06% | +157.65% | +83.38% | +79.17% | -10.74% | +1,279.31% | 9.39B | |
| +0.05% | -0.63% | -0.49% | +37.11% | +66.20% | +148.73% | +661.99% | +216.80% | +1,070.65% | 9.39B | |
| -0.66% | -9.26% | -1.61% | -25.38% | -29.65% | -13.59% | +35.04% | +53.47% | +91.83% | 9.31B | |
| Average | -0.62% | -2.24% | +1.34% | +32.92% | +28.55% | +91.54% | +234.26% | +70.38% | +635.33% | 18.5B | |
| Weighted average by Cap. | -0.85% | -2.78% | -0.02% | +29.21% | +33.44% | +91.25% | +188.56% | +85.10% | +563.56% |
- Stock Market
- Stocks
- MACK Stock
- Sector Merrimack Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
